Navigation Links
Connecticut's Universities Team Up to Host 2009 Stem Cell Symposium
Date:10/6/2008

Scientific presentations and workshops to highlight two day event

NEW HAVEN, Conn., Oct. 6 /PRNewswire/ -- The StemCONN 09 stem cell symposium will bring the stem cell research community to New Haven, Conn., March 23 - 24, 2009.

Building on the successful StemCONN 07, which brought 700 scientists, business leaders and students to Hartford last year, StemCONN 09 will showcase the latest advances in stem cell research and their potential medical applications. Included in the two day event are scientific presentations by leading authorities, as well as sessions on the translation of scientific research to the clinic, emerging technologies and bioethics.

StemCONN 09 will include:

-- A scientific session featuring presentations by Kevin Eggan Ph.D. and

Konrad Hochedlinger Ph.D., both of Harvard University; Craig T. Jordan

Ph.D., University of Rochester; Thomas A. Rando M.D., Ph.D., of Stanford

University; Celeste Simon Ph.D., University of Pennsylvania, and Sally

Temple Ph.D., Albany Medical Center.

-- A session on bioethics organized by Lori Gruen Ph.D., of Wesleyan

University in collaboration with Anne Hiskes Ph.D., of the University of

Connecticut.

-- A session on "Translation to Clinic" that will look at the

opportunities and barriers to converting stem cell research to therapies

as well as promising options for using stem cells for drug discovery.

With its 10-year, $100 million stem cell research grant program, Connecticut has emerged as an innovative leader in the field of stem cell research. The state is home to leading academic institutions specializing in this area, including Yale University, the University of Connecticut and Wesleyan University, providing a culture where national and international stem cell research partnerships develop, thrive and grow.

Organizing StemCONN 09 are Yale University, Wesleyan University and the University of Connecticut. Conference management is being provided by CURE (Connecticut United for Research Excellence), the Connecticut lifescience association. Also represented on the organizing committee are the Connecticut Academy of Science and Engineering and founding partners the Connecticut Department of Public Health and the Connecticut Stem Cell Coalition.

Confirmed sponsors include Yale University School of Medicine, University of Connecticut, Wesleyan University and the Connecticut Department of Public Health.

For more information on sponsorship and pre-registration, visit http://www.stemconn.org.


'/>"/>
SOURCE CURE (Connecticut United for Research Excellence)
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Aerospace engineer earns Oak Ridge Associated Universities Ralph Powe Junior Faculty Award
2. Investment Firm Allied Minds to Commercialize New Frozen Aliquotter Technology with Two Local Major Universities.
3. MaxCyte and Medinet to Present at the 10th International Symposium on Dendritic Cells in Kobe, Japan
4. Ardea Biosciences to Present Data on Lead MEK inhibitor, RDEA119, at EORTC-NCI-AACR Symposium
5. Poniard Pharmaceuticals to Present at the 4th Annual Moores UCSD Cancer Center Translational Oncology Symposium
6. Aureus Pharma Announces Date of 2008 Annual User Symposium
7. Access Pharmaceuticals Presents New Data at International Symposium Showing Companys Angiolix(R) Monoclonal Antibody has Potential to Treat Cancer by Attacking Cancer Stem Cells
8. BioHorizons Global Symposium 2008 Combines Record Attendance with Groundbreaking Technology
9. International Center for Adult Stem Cell Education Debuts at Spinal Cord Injury Symposium in Greece
10. CryoLife Conducts Surgeons Cardiac Allograft Symposium
11. DuoCort Hosts Adrenal Insufficiency Symposium at the 10th European Congress of Endocrinology in Berlin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... a mission to bring innovative medical technologies, services and solutions to the healthcare ... development and implementation of various distribution, manufacturing, sales and marketing strategies that are ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young ... cancer. Members of the Class of 2016 were selected from a pool of ... More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:6/22/2016)... 22, 2016  The American College of Medical Genetics and ... Magazine as one of the fastest-growing trade shows during ... the Bellagio in Las Vegas . ... of growth in each of the following categories: net square ... number of attendees. The 2015 ACMG Annual Meeting was ranked ...
(Date:6/20/2016)... 2016 Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring announced that ... has secured the final acceptance by all three ... Access Systems (MAS) installed. Furthermore, Securus will have ... installed by October, 2016. MAS distinguishes between legitimate ...
(Date:6/9/2016)... , June 9, 2016 ... deploy Teleste,s video security solution to ensure the safety of ... during the major tournament Teleste, an ... systems and services, announced today that its video security solution ... to back up public safety across the country. The ...
Breaking Biology News(10 mins):